# REsponse to Combined SONS and ONS in Chronic Cluster headachE

> **NCT05868044** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Salvia BioElectronics** · enrollment: 5 (estimated)

## Conditions studied

- Chronic Cluster Headache

## Interventions

- **DEVICE:** PRIMUS

## Key facts

- **NCT ID:** NCT05868044
- **Lead sponsor:** Salvia BioElectronics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-02
- **Primary completion:** 2024-04-23
- **Final completion:** 2026-12-30
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05868044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05868044, "REsponse to Combined SONS and ONS in Chronic Cluster headachE". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05868044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*